Non-Small Cell Lung Cancer Archives - Oncology Nurse Advisor

Non-Small Cell Lung Cancer

OncoTargets and Therapy

Pulmonary Lymphoepithelioma-Like Carcinoma: A Mini-Review

[OncoTargets and Therapy] PLELC is a rare and distinct subtype of NSCLC associated with Epstein-Barr virus infection. Usually detected at early stage, prognosis is better for patients with PLELC than for those with other subtypes of NSCLC. This review discusses etiology, diagnosis, and treatment of the disease.

Opdivo Plus Yervoy With Limited Chemotherapy Approved for First-Line Metastatic or Recurrent NSCLC

The Food and Drug Administration (FDA) has approved the combination of Opdivo (nivolumab; Bristol Myers Squibb) plus Yervoy (ipilimumab; Bristol Myers Squibb) and 2 cycles of platinum-doublet chemotherapy, for the first-line treatment of adult patients with metastatic or recurrent non-small cell lung cancer (NSCLC), with no EGFR or ALK genomic tumor aberrations.

Next post in Lung Cancer